Thank you for the reply and i think a lot here agree on on the company side regarding timelines and promises.
Regarding the drug, you've called it old a few times, but does this matter? Is it rare for drugs to be repurposed or to be bought by a different company a used slightly differently?
Surely CYDY isn't the only company with an "old drug" that they're trying to make work for covid, right?
You are 100% correct, old drugs for Covid make no difference. Dexamethazone is the perfect example here.
For HIV, research is advancing, it’s expected, but not guaranteed, that new drugs have an advantage.